These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30863499)

  • 1. POPX2 is a novel LATS phosphatase that regulates the Hippo pathway.
    Rahmat MB; Zhang S; Koh CG
    Oncotarget; 2019 Feb; 10(15):1525-1538. PubMed ID: 30863499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of PTPN12 Phosphatase as a Novel Negative Regulator of Hippo Pathway Effectors YAP/TAZ in Breast Cancer.
    Sarmasti Emami S; Ge A; Zhang D; Hao Y; Ling M; Rubino R; Nicol CJB; Wang W; Yang X
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion.
    Nouri K; Azad T; Lightbody E; Khanal P; Nicol CJ; Yang X
    FASEB J; 2019 Nov; 33(11):12487-12499. PubMed ID: 31431076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway.
    Lu J; Hu Z; Deng Y; Wu Q; Wu M; Song H
    J Biol Chem; 2021; 296():100400. PubMed ID: 33571521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Role of Hippo-YAP (Yes-Associated Protein)/TAZ (Transcriptional Coactivator with PDZ-Binding Motif) Pathway Dysregulation in Renal Cell Carcinoma Progression.
    Mondal V; Higgins PJ; Samarakoon R
    Cancers (Basel); 2024 Aug; 16(15):. PubMed ID: 39123485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMOylation of large tumor suppressor 1 at Lys751 attenuates its kinase activity and tumor-suppressor functions.
    Mei L; Yuan L; Shi W; Fan S; Tang C; Fan X; Yang W; Qian Y; Hussain M; Wu X
    Cancer Lett; 2017 Feb; 386():1-11. PubMed ID: 27847303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MARK4 inhibits Hippo signaling to promote proliferation and migration of breast cancer cells.
    Heidary Arash E; Shiban A; Song S; Attisano L
    EMBO Rep; 2017 Mar; 18(3):420-436. PubMed ID: 28183853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP21 regulates Hippo pathway activity by mediating MARK protein turnover.
    Nguyen HT; Kugler JM; Loya AC; Cohen SM
    Oncotarget; 2017 Sep; 8(38):64095-64105. PubMed ID: 28969054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of YAP by the Hippo pathway is involved in intervertebral disc degeneration, cell contact inhibition, and cell senescence.
    Zhang C; Wang F; Xie Z; Chen L; Sinkemani A; Yu H; Wang K; Mao L; Wu X
    Oncotarget; 2018 Jan; 9(2):2175-2192. PubMed ID: 29416763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARD3 induces TAZ activation and cell growth by promoting LATS1 and PP1 interaction.
    Lv XB; Liu CY; Wang Z; Sun YP; Xiong Y; Lei QY; Guan KL
    EMBO Rep; 2015 Aug; 16(8):975-85. PubMed ID: 26116754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Roles of NDR Protein Kinases in Hippo Signalling.
    Hergovich A
    Genes (Basel); 2016 May; 7(5):. PubMed ID: 27213455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(rC)-Binding Protein 2 Regulates Hippo Signaling To Control Growth in Breast Epithelial Cells.
    Li F; Bullough KZ; Vashisht AA; Wohlschlegel JA; Philpott CC
    Mol Cell Biol; 2016 Aug; 36(16):2121-31. PubMed ID: 27215387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippo-Independent Regulation of Yki/Yap/Taz: A Non-canonical View.
    Cho YS; Jiang J
    Front Cell Dev Biol; 2021; 9():658481. PubMed ID: 33869224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geranylgeranylation signals to the Hippo pathway for breast cancer cell proliferation and migration.
    Mi W; Lin Q; Childress C; Sudol M; Robishaw J; Berlot CH; Shabahang M; Yang W
    Oncogene; 2015 Jun; 34(24):3095-106. PubMed ID: 25109332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. POPX2 phosphatase regulates apoptosis through the TAK1-IKK-NF-κB pathway.
    Weng T; Koh CG
    Cell Death Dis; 2017 Sep; 8(9):e3051. PubMed ID: 28906490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
    Juan WC; Hong W
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Under-expression of LATS1 promotes the differentiation, proliferation and migration of mesenchymal stem cells by inhibition the Hippo signaling pathway in vitro].
    Li L; Dong L; Hui J; Gao F; Wang Q; Yang L; Zhang J; Yan J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Aug; 29(8):731-737. PubMed ID: 28795673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hippo signaling pathway in liver regeneration and tumorigenesis.
    Hong L; Cai Y; Jiang M; Zhou D; Chen L
    Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):46-52. PubMed ID: 25476204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippo pathway - brief overview of its relevance in cancer.
    Zygulska AL; Krzemieniecki K; Pierzchalski P
    J Physiol Pharmacol; 2017 Jun; 68(3):311-335. PubMed ID: 28820389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy.
    Ercolani C; Di Benedetto A; Terrenato I; Pizzuti L; Di Lauro L; Sergi D; Sperati F; Buglioni S; Ramieri MT; Mentuccia L; Gamucci T; Perracchio L; Pescarmona E; Mottolese M; Barba M; Vici P; De Maria R; Maugeri-Saccà M
    Cancer Biol Ther; 2017 May; 18(5):339-346. PubMed ID: 28387539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.